tiprankstipranks
Trending News
More News >
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
US Market

China SXT Pharmaceuticals (SXTC) Income Statement

Compare
274 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q4 2025), China SXT Pharmaceuticals's total revenue was $455.71K, a decrease of -7.84% from the same quarter last year. In Q4, China SXT Pharmaceuticals's net income was $-1.25M. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.74M$ 1.93M$ 1.97M$ 2.60M$ 4.78M
Gross Profit
$ 367.43K$ 553.97K$ 426.27K$ 1.25M$ 2.84M
Operating Expenses
$ 3.05M$ 3.07M$ 6.03M$ 6.44M$ 5.04M
Depreciation and Amortization
$ 82.30K$ 203.25K$ 250.16K$ 320.01K$ 345.41K
EBITDA
$ -2.57M$ -2.35M$ -5.21M$ -5.05M$ -1.85M
Operating Income
$ -2.68M$ -2.52M$ -5.61M$ -5.19M$ -2.20M
Other Income/Expenses
$ -623.17K$ -583.32K$ -327.26K$ -218.28K$ -743.79K
Pretax Income
$ -3.30M$ -3.10M$ -5.93M$ -5.41M$ -2.94M
Net Income
$ -3.30M$ -3.10M$ -5.93M$ -5.74M$ -2.75M
Per Share Metrics
Basic EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Diluted EPS
$ -8.18$ -3.57$ -22.23$ -137.92$ -95.48
Weighted Average Shares Outstanding
403.92K 867.42K 266.97K 41.59K 28.78K
Weighted Average Shares Outstanding (Diluted)
403.92K 867.42K 266.97K 41.59K 28.78K
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History